Placement Completed
OncoSil Medical placement
A$8m raised
Announced 3 Feb 2026 · ASX: OSL · A$0.68 cash per share
Advisers
OncoSil Medical
Issuer
Not disclosed
Lead managers
- Lead manager
- Bookrunner
- Underwriter
- Issuer
- OncoSil Medical
- Completed
- 9 Feb 2026
- Sector
- Medical devices and technology
Similar deals
- Singular Health Group placement Jun 2025 · A$8m · Medical devices and technology
- Hydrix entitlement offer May 2026 · A$8.2m · Medical devices and technology
- BlinkLab placement May 2025 · A$7.7m · Medical devices and technology
- Adherium entitlement offer Feb 2026 · A$7.5m · Medical devices and technology
- PainChek placement Jul 2025 · A$7.5m · Medical devices and technology
Sources
- 3 Feb 2026 $8.0 million Capital Raise for Ongoing Commercial Expansion ASX
- 9 Feb 2026 Application for quotation of securities - OSL ASX